NordicAST

The NordicAST (Nordic Committee on Antimicrobial Susceptibility Testing) is a working group for methodology in antimicrobial susceptibility testing including members from Sweden, Norway, Denmark, Finland and Iceland. The group was first formed on 1 January 2011 by Sweden, Norway and Denmark but in 2016 Finland and Iceland were included in the group and the official language was changed to English. The group members are appointed by the Swedish Society for Medical Microbiology (three members), the Norwegian Working Group on Antibiotics (NWGA; three members) the Danish methodology group (Danres-M; three members) and the Finnish Study Group for Antimicrobial Resistance (FIRe; three members).

More information is found on the NordicAST website.

Tick Borne Diseases Group

The NSCMID tick-borne diseases group is a multi-professional network for exchanging and sharing knowledge in the field of tick-borne infections. It originates mainly from collaborations formed within ScandTick Innovation, an EU-funded inter-regional project in the Öresund-Kattegatt-Skagerrak region. In 2015 the network was expanded to include colleagues from Finland, and in 2016 it was included as an NSCMID working group. The group will organize workshops and meetings (such as the biannual NordTick meeting), promote collaborative research projects and support networking between physicians and researchers both within and outside the Nordic countries.

Contact: Anna J Henningsson, M.D, Ph.D., Region Jönköping county, Sweden. Per-Eric Lindgren, professor, Linköping University, Sweden.

High level isolation working group

 The group consists of doctors and nurses who work in hospitals that have high level isolation fascilities. The group met for the first time in Copenhagen in december 2016 where they exchanged experiences and knowledge about preparedness, planning and caretaking of patients with highly contagious diseases. The group found that the Nordic countries have very similar fascilities and also similar challenges in this area and therefore may gain from a closer collaboration in the future sharing knowledge and practising together.

The group will meet again in 2017 in Norway.

 

EHEC/STEC Group

Improved molecular diagnostics is of indispensable value for detecting clinical disease cases and carriage of EHEC/STEC. With the advent of the novel diagnostics, however, there is a need for agreeing on diagnostic criteria and on how to handle infection ranging from asymptomatic carriage to severe clinical disease. This working group was created to provide a platform for discussing these issues in a Nordic context.

Contact: Andreas Matussek, Head of Karolinska Universitetslaboratoriet, Stockholm, Sweden.